World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
43234
World Ranking
7010
National Ranking
3684

Overview

Eileen M. O'Reilly is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research work spans multiple areas in medicine, particularly in oncology, where they have contributed significantly to the study of cancer biology and treatment methodologies.

Their publication record includes numerous papers focused on pancreatic cancer and related oncological fields. Notable recent papers include:

  • "Pancreatic Cancer," published in 2021 in JAMA
  • "Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer," published in 2023 in Nature
  • "Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients," published in 2022 in Cell
  • "Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation," published in 2020 in Journal of Clinical Oncology
  • "Preoperative Treatment of Locally Advanced Rectal Cancer," published in 2023 in New England Journal of Medicine

Their core fields of study are medicine and biochemistry, genetics, and molecular biology. Within these broader domains, their subfields predominantly cover oncology, cancer research, pulmonary and respiratory medicine, surgery, and molecular biology.

Key topics addressed in their research include:

  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Renal Cell Carcinoma Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Colorectal Cancer Treatments and Studies
  • Neuroendocrine Tumor Research Advances

O'Reilly has frequently published in high-impact journals with a substantial number of papers appearing in:

  • Journal of Clinical Oncology
  • Cancer Research
  • Annals of Oncology
  • Annals of Surgical Oncology
  • Neuromuscular Disorders

Collaborations with other researchers are prominent in their career. Their most frequent co-authors include:

  • Wungki Park
  • Jeffrey A. Meyerhardt
  • Kenneth H. Yu
  • Anna M. Varghese
  • Ghassan K. Abou-Alfa

Best Publications

  • Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

    Talia Golan;Pascal Hammel;Michele Reni;Eric Van Cutsem

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Ayuko Hoshino;Ayuko Hoshino;Han Sang Kim;Han Sang Kim;Linda Bojmar;Linda Bojmar;Linda Bojmar;Kofi Ennu Gyan

  • Pancreatic Cancer: A Review

    Wungki Park;Akhil Chawla;Eileen M O'Reilly;Eileen M O'Reilly

  • Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology

    Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Horacio Asbun

  • Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

    Hedy Lee Kindler;Donna Niedzwiecki;Donna Hollis;Susan Sutherland

  • Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

    Itaru Endo;Mithat Gonen;Adam C. Yopp;Kimberly M. Dalal

  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

    Alan P. Venook;Donna Niedzwiecki;Heinz Josef Lenz;Federico Innocenti

  • Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

    Philip A. Philip;Jacqueline Benedetti;Christopher L. Corless;Ralph Wong

  • Multicenter Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

    Manish A. Shah;Ramesh K. Ramanathan;David H. Ilson;Alissa Levnor

  • Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer

    Alicia Latham;Preethi Srinivasan;Yelena Kemel;Jinru Shia

  • Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).

    A. Duffy;M. Capanu;G.K. Abou-Alfa;D. Huitzil

  • Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial.

    Eileen M. O'Reilly;Do Youn Oh;Neesha Dhani;Daniel J. Renouf

  • Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

    Joseph M. Herman;Daniel T. Chang;Karyn A. Goodman;Avani S. Dholakia

  • Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

    Diana Mandelker;Liying Zhang;Yelena Kemel;Yelena Kemel;Zsofia K. Stadler;Zsofia K. Stadler

  • Intrahepatic Cholangiocarcinoma: expert consensus statement

    Sharon M. Weber;Dario Ribero;Eileen M. O'Reilly;Norihiro Kokudo

  • Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.

    Maeve A. Lowery;Ryan Ptashkin;Emmet Jordan;Michael F. Berger

  • Impact of primary (1{o}) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).

    Alan P. Venook;Donna Niedzwiecki;Federico Innocenti;Briant Fruth

  • Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

    Davendra P.S. Sohal;Pamela B. Mangu;Alok A. Khorana;Manish A. Shah

  • Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix.

    Laura H Tang;Jinru Shia;Robert A Soslow;Deepti Dhall

  • Tumour lineage shapes BRCA-mediated phenotypes.

    Philip Jonsson;Chaitanya Bandlamudi;Michael L Cheng;Michael L Cheng;Preethi Srinivasan

Frequent Co-Authors

Ghassan K. Abou-Alfa
Ghassan K. Abou-Alfa Memorial Sloan Kettering Cancer Center
David P. Kelsen
David P. Kelsen Memorial Sloan Kettering Cancer Center
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
Peter J. Allen
Peter J. Allen Duke University
David S. Klimstra
David S. Klimstra Yale University
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Alan P. Venook
Alan P. Venook University of California, San Francisco
Manish A. Shah
Manish A. Shah Cornell University
Hedy L. Kindler
Hedy L. Kindler University of Chicago
Jeffrey A. Meyerhardt
Jeffrey A. Meyerhardt Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA doesn’t have to mean the traditional path of medical school. Many students are turning to flexible, online alternatives that offer career opportunities in healthcare. For example, if you are interested in a fast entry into the medical field, medical coding is a promising option. Discover the requirements and expenses involved by reading how much does it cost to become a medical coder.

Nursing is another popular pathway. There are a number of online nurse practitioner programs that allow you to advance your clinical skills while studying remotely. Entry-level nursing is also accessible online; some of the cheapest online nursing program options can make this career more affordable than ever.

For those already holding a nursing degree, an advanced credential can open doors to leadership and research roles. You can see a selection of online phd nursing programs designed for working professionals.

These online degrees provide flexible pathways into growing healthcare careers, often at a lower cost and faster pace than traditional routes.

Best Scientists Citing Eileen M. O’Reilly

Trending Scientists

Recently Published Articles